Travere Therapeutics (NASDAQ:TVTX – Get Free Report) released its earnings results on Tuesday. Travere Therapeutics had a negative return on equity of 26.16% and a negative net margin of 4.00%. Travere Therapeutics Stock PerformanceTVTX traded up $1.26 during trading on Tuesday, hitting $56.24. Travere Therapeutics has a one year low of $15.60 and a one year high of $60.10. Also, insider William E. Rote sold 2,763 shares of Travere Therapeutics stock in a transaction dated Wednesday, May 6th.